Insiders · Profile

ABALLI JOHN

President and CEO at EXAGEN. Filing since 8 Dec 2022. CIK 0001843113

Company

Date

Role

Action

Shares

Amount

Of holding

XGN EXAGEN INC.

3 Mar 2026

President and CEO

Sold at will

15,698

$56.83K

2.2%

XGN EXAGEN INC.

24 Feb 2026

President and CEO

Sold at will

11,430

$41.26K

1.6%

XGN EXAGEN INC.

16 Oct 2025

President and CEO

Sold at will

31,787

$375.60K

4.3%

XGN EXAGEN INC.

14 Nov 2024

President and CEO

Bought

24,305

$68.30K

3.7%

XGN EXAGEN INC.

16 May 2024

President and CEO

Bought

40,401

$77.57K

opened

XGN EXAGEN INC.

17 Oct 2023

President and CEO

Sold at will

33,819

$59.02K

7.5%

XGN EXAGEN INC.

8 Dec 2022

President and CEO

Bought

90,000

$241.20K

25.7%

7 decisions on file.